These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 864473)

  • 1. Tetrahydro-beta-carbolines: specific inhibitors of type A monoamine oxidase in rat brain.
    Meller E; Friedman E; Schweitzer JW; Friedhoff AJ
    J Neurochem; 1977 May; 28(5):995-1000. PubMed ID: 864473
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1977 Nov; 26(21):1991-6. PubMed ID: 921812
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tetrahydro-beta-carbolines on monoamine oxidase and serotonin uptake in mouse brain.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1976 Oct; 25(20):2319-31. PubMed ID: 985563
    [No Abstract]   [Full Text] [Related]  

  • 4. beta-Carbolines as selective monoamine oxidase inhibitors: in vivo implications.
    Glover V; Liebowitz J; Armando I; Sandler M
    J Neural Transm; 1982; 54(3-4):209-18. PubMed ID: 7130973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tryptolines (1, 2, 3, 4-tetrahydro-beta-carbolines) on monoamine metabolism and the platelet aggregation response in human platelets.
    Youdim MB; Oppenheim B
    Neuroscience; 1981; 6(4):801-10. PubMed ID: 7242917
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the reuptake of serotonin by tryptoline.
    Rommelspacher H; Bade P; Coper H; Kossmehl G
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):93-5. PubMed ID: 934360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of an indole-hydrazide derivative as inhibitor of mouse brain type A monoamine oxidase.
    Gurpegui M; Monge A; Fuentes JA
    Arzneimittelforschung; 1981; 31(10):1710-2. PubMed ID: 7198447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain serotonin and 5-hydroxyindoleacetic acid concentrations and serotonin synthesis following tetrahydro-beta-carboline administration in mice.
    Buckholtz NS
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(3):215-21. PubMed ID: 6164934
    [No Abstract]   [Full Text] [Related]  

  • 9. 6-Methoxy-1,2,3,4-tetrahydro-beta-carboline: a specific monoamine oxidase-A inhibitor in CF-1 mouse brain.
    Sparks DL; Buckholtz NS
    Neurosci Lett; 1980 Oct; 20(1):73-8. PubMed ID: 7052551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the oxidation of 5-hydroxytryptamine and 3,4-dimethoxyphenylethylamine in rat, dog and human brain.
    Huszti Z; Borsy J
    J Neurochem; 1968 Dec; 15(12):1407-13. PubMed ID: 5729421
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of tetrahydro-beta-carbolines with brain serotonin metabolism.
    Buckholtz NS
    Prog Clin Biol Res; 1982; 90():183-90. PubMed ID: 7111318
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 13. Benzylhydrazine--a selective inhibitor of human and rat brain monoamine oxidase.
    Roth JA
    Biochem Pharmacol; 1979 Mar; 28(6):729-32. PubMed ID: 454471
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamine oxidase inhibition by beta-carbolines: a quantum chemical approach.
    Tomás F; Aulló JM
    J Pharm Sci; 1979 Jun; 68(6):772-6. PubMed ID: 458582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of monoamine oxidase inhibition by three 2-indolylmethylamine derivatives.
    Cruces MA; Elorriaga C; Fernández-Alvarez E
    Biochem Pharmacol; 1990 Aug; 40(3):535-43. PubMed ID: 2383286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of various tryptolines (tetrahydro-beta-carbolines) on 5-hydroxytryptamine receptors.
    Holman RB
    Prog Clin Biol Res; 1982; 90():167-81. PubMed ID: 6287489
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonergic activity of a novel tetrahydro-beta-carboline.
    Davis PA; Baird-Lambert J; Taylor KM; Maclaren JA
    Biochem Pharmacol; 1979 Jun; 28(11):1803-6. PubMed ID: 475840
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurobiology of tetrahydro-beta-carbolines.
    Buckholtz NS
    Life Sci; 1980 Sep; 27(11):893-903. PubMed ID: 6107810
    [No Abstract]   [Full Text] [Related]  

  • 19. Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.
    Langer SZ; Raisman R; Tahraoui L; Scatton B; Niddam R; Lee CR; Claustre Y
    Eur J Pharmacol; 1984 Feb; 98(1):153-4. PubMed ID: 6325207
    [No Abstract]   [Full Text] [Related]  

  • 20. Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine.
    Fuller RW; Hemrick SK
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):199-202. PubMed ID: 663404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.